Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations (Parenthetical)

v3.19.1
Consolidated Statements of Operations (Parenthetical) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
General and administrative costs, to related parties $ 759,738 $ 83,686
Research and development costs, to Theradex $ 22,198 $ 105,698